MR contrast agent at high-field MRI (3 Tesla)

Area of Science:

• Radiology and Imaging
• Neuro-oncology
• Medical Physics

Background:

• Magnetic Resonance Imaging (MRI) is crucial for diagnosing brain tumors.
• Higher magnetic field strengths (e.g., 3 Tesla) may offer improved image quality and diagnostic capabilities compared to lower strengths (e.g., 1.5 Tesla).

Purpose of the Study:

• To compare the efficacy of 3 Tesla (3 T) MRI versus 1.5 Tesla (1.5 T) MRI in visualizing brain tumors and metastases after gadolinium administration.
• To evaluate the diagnostic performance of different MRI sequences at varying field strengths for specific brain pathologies, including pituitary adenomas and for MR venography.

Main Methods:

• Patients with primary and secondary brain tumors underwent MRI scans at both 1.5 T and 3 T.
• MP-RAGE and T1-SE sequences were utilized with gadolinium-based contrast agents.
• Evaluations included tumor-to-brain contrast, detection of metastases, assessment of pituitary adenomas, and MR venography quality.

Main Results:

• Tumor-to-brain contrast was significantly higher at 3 T than at 1.5 T.
• 3 T MRI, particularly with cumulative triple-dose imaging, demonstrated superior detection of brain metastases compared to 1.5 T.
• Contrast-enhanced 3 T MRI improved diagnosis of cavernous sinus infiltration in macroadenomas and visualization of cranial nerves.
• 3 T MR venography provided greater detail due to higher spatial resolution and enhanced susceptibility weighting.

Conclusions:

• Gadolinium-enhanced 3 T MRI offers superior tumor-to-brain contrast and enhanced detection of cerebral metastases compared to 1.5 T.
• 3 T MRI provides significant advantages in evaluating pituitary macroadenomas and performing MR venography, yielding more detailed information.
• The increased signal-to-noise ratio and spatial resolution at 3 T make it a clinically attractive option for comprehensive brain tumor imaging.